Analgesic Effects of Gabapentin After Scoliosis Surgery in Children
|ClinicalTrials.gov Identifier: NCT00684112|
Recruitment Status : Completed
First Posted : May 26, 2008
Last Update Posted : August 16, 2013
|Condition or disease||Intervention/treatment||Phase|
|Scoliosis||Drug: Gabapentin Drug: Placebo||Phase 3|
Surgical correction of scoliosis involves major orthopedic surgery, and can lead to severe acute postoperative pain and persistent neuropathic pain. The mainstays of treating postoperative pain are acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), systemic opioids, and local anesthetic techniques. Despite being effective, their use is limited by adverse side effects. Acute postoperative pain involves multiple mechanisms and neural pathways, therefore a combination of different analgestic medications acting through different mechanisms, may be the most effective treatment. This strategy may also reduce the need for, and side effects of, using high doses of any one particular class of drugs.
Gabapentin is safe and well tolerated with few side effects and has minimal interactions with other drugs. The use of gabapentin to treat acute postoperative pain may improve quality of analgesia, result in decreased requirements for opioids and might consequently reduce the incidence of opioid induced side effects. It may also have a direct effect on postoperative nausea and vomiting, and decrease the incidence of persistent neuropathic pain. These qualities make gabapentin an attractive agent for use in management of postoperative pain in children undergoing corrective spinal injury.
The primary aim of this study is to determine whether the use of gabapentin will improve postoperative analgesia and reduce opioid consumption and side effects in children undergoing corrective spinal surgery for idiopathic scoliosis. Secondary aims are to evaluate whether use of gabapentin reduces pain scores, decreases postoperative nausea and vomiting, decreases persisting pain and improves patient satisfaction.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||35 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Analgesic Effects of Gabapentin After Scoliosis Surgery in Children|
|Study Start Date :||May 2008|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||February 2010|
Single dose preoperative gabapentin
Patients in this arm of the study will receive two identical capsules, containing 300 mg of oral gabapentin each, 1 hour before surgery.
Placebo Comparator: Placebo Control
Single dose preoperative placebo control
Patients in this arm of the study will receive two identical placebo capsules 1 hour before surgery.
- Total morphine consumption postoperatively. [ Time Frame: 0 to 24 hours postoperatively ]
- Time to first rescue analgesia. [ Time Frame: Determined by outcome ]
- Pain intensity scores at rest and with movement [ Time Frame: Assessed at 1 hour, 4 hours, 12 hours, 24 hours, 72 hours, and 1 week postoperatively and at the 6-week outpatient follow up visit. ]
- Incidence and severity of nausea, vomiting, pruritis, sedation, dizziness, and presence of persisting pain symptoms [ Time Frame: Assessed at 1 hour, 4 hours, 12 hours, 24 hours, and 48 hours postoperatively. ]
- Time to first postoperative oral intake as a measure of bowel function. [ Time Frame: Determined by outcome ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00684112
|The Hospital for Sick Children|
|Toronto, Ontario, Canada, M5G 1X8|
|Principal Investigator:||Arie Peliowski, MD||The Hospital for Sick Children, Toronto Canada|